Vanda Pharmaceuticals
VNDA
#7486
Rank
A$0.62 B
Marketcap
A$10.55
Share price
4.15%
Change (1 day)
40.97%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -A$0.19 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.21 Billion. In 2024 the company made an earning of -A$61.03 Million a decrease over its 2023 earnings that were of -A$20.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.19 Billion208.27%
2024 -A$61.03 Million191.43%
2023 -A$20.94 Million-320.45%
2022 A$9.49 M-84.99%
2021 A$63.28 M54.8%
2020 A$40.88 M19.42%
2019 A$34.23 M4.93%
2018 A$32.62 M-228.6%
2017 -A$25.37 Million-8.98%
2016 -A$27.88 Million-53.79%
2015 -A$60.31 Million-30.18%
2014 -A$86.38 Million173.08%
2013 -A$31.64 Million-25.33%
2012 -A$42.37 Million163.61%
2011 -A$16.07 Million-221.15%
2010 A$13.26 M-124.53%
2009 -A$54.08 Million-29.44%
2008 -A$76.64 Million-36.2%
2007 -A$0.13 Billion21.81%
2006 -A$98.62 Million170.55%
2005 -A$36.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$24.64 B-13,658.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$33.77 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.61 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.05 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.78 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-A$4.21 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.65 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA